Scientists have found the first animal evidence supporting a theory that's haunted neurology for decades: a virus can damage your nervous system long after you've recovered from the infection itself, potentially triggering ALS.
Researchers at Texas A&M identified a specific mouse strain — CC023 — that develops ALS-like symptoms after being infected with a common mouse virus. What makes this discovery significant is that the mice cleared the virus from their bodies, yet the neurological damage persisted. Their spinal cords showed lesions and their muscles wasted away, mimicking what happens in human ALS patients.
"This is the first animal model that actually confirms what we've suspected," says Candice Brinkmeyer-Langford, a neurodegenerative disease expert at Texas A&M. The finding matters because it opens a path to understanding sporadic ALS — the form that accounts for over 90% of cases and isn't inherited.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxHow the virus leaves lasting damage
In the study, published in the Journal of Neuropathology & Experimental Neurology, researchers infected five genetically different mouse strains with Theiler's murine encephalomyelitis virus (TMEV) and tracked what happened over weeks and months. Within the first two weeks, all strains showed nerve damage in the lumbar spine. But here's where genetics mattered: only the CC023 strain developed permanent muscle wasting and ALS-like lesions even after the virus disappeared.
The pattern was striking. The immune system fought the virus aggressively at first, triggering inflammation and damage to nerve tissue. Once the virus was cleared, the immune response stopped — but the damage remained. In most mice, the spinal cord recovered. In CC023 mice, it didn't.
This suggests that certain genetic profiles make people vulnerable not to the virus itself, but to the lasting neurological consequences of fighting it. Your genes may determine whether a viral infection becomes a temporary illness or a trigger for permanent nerve damage.
What comes next
The CC023 model gives researchers a way to hunt for biomarkers — the early warning signs that appear after infection but before symptoms develop. If scientists can identify those markers in humans, it could lead to tests that flag who's at risk, and eventually treatments that prevent the cascade of damage. For the 16,000 Americans diagnosed with ALS each year, most of whom have no family history, this could reshape how the disease is understood and treated.
